Patent Attorney
Sungmin CHOIP Litigation
Korean, English and Japanese |
Newsletter
Recent IP Developments in Korea 2025.02.19Deals & Cases
Prevailing on all claims in a patent invalidation action relating to hafnium precursors 2024.09.14Newsletter
Recent IP Developments in Korea 2024.08.21Deals & Cases
Securing a series of wins in a patent dispute involving the rare disease treatment Soliris® 2024.04.25Newsletter
Recent IP Developments in Korea 2024.02.26Press & Releases
[Hankyung] Lee & Ko Prevails in All 10 Lawsuits Relating to Boryung Pharmaceutical’s Ducarb® Patent 2023.12.05Deals & Cases
Lee & Ko wins all 10 cases for domestic blockbuster drug Dukarb® 2023.11.30Deals & Cases
Obtained a victory in a patent invalidation action related to the Soliris® use patent 2023.02.10Press & Releases
[Chosun Biz] [Law Firm's Technology] The First Case to Admit a Domestic Pharmaceutical Company’s Patent Infringement Claim under the Doctrine of Equivalents... Lee & Ko’s Landmark Success in Protecting Boryung’s Original Hypertension Drug 2022.05.04